Tuis8QQ • FRA
add
AbCellera Biologics Inc
Vorige sluiting
€2,46
Dagwisseling
€2,44 - €2,44
Jaarwisseling
€2,16 - €5,43
Markkapitalisasie
845,69 m USD
Gemiddelde volume
413,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 7,32 m | -27,18% |
Bedryfskoste | 59,85 m | 139,67% |
Netto inkomste | -36,93 m | -20,97% |
Netto winsgrens | -504,30 | -66,12% |
Wins per aandeel | -0,13 | -18,18% |
EBITDA | -56,93 m | -24,36% |
Effektiewe belastingkoers | 23,36% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 670,36 m | -15,75% |
Totale bates | 1,41 mjd | -8,11% |
Totale aanspreeklikheid | 301,51 m | -11,93% |
Totale ekwiteit | 1,11 mjd | — |
Uitstaande aandele | 294,67 m | — |
Prys om te bespreek | 0,65 | — |
Opbrengs op bates | -16,25% | — |
Opbrengs op kapitaal | -19,58% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -36,93 m | -20,97% |
Kontant van bedrywe | -29,97 m | -250,56% |
Kontant van beleggings | 52,10 m | 251,49% |
Kontant van finansiering | 2,65 m | 532,70% |
Netto kontantverandering | 24,74 m | 286,42% |
Beskikbare kontantvloei | -42,55 m | -1 686,49% |
Meer oor
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
HUB
Gestig
2012
Hoofkwartier
Webwerf
Werknemers
586
